Industry Symposia Program

Symposia program

zydus life logo

  • A New Dawn of Treatment for Anemia in CKD
  • Organized by Zydus Lifesciences
  • Friday 23 September – 12:45 – 13:45
  • Moderators: Vivekanand Jha, Dibya Singh Shah
  • Title Speaker
    The global burden of anemia in CKD N. Gopalakrishnan
    The unmet treatment need in CKD anemia Manisha Sahay
    A responsible use of HIF-PHIs – a new addition to the treatment arsenal Dinesh Khullar
    Panel discussion

    Vijay Kher

    Narayan Prasad

    Umesh Khanna

    Tarun Jeloka

    Chula Herath

    Urmila Anandh

  • Induction and Infection in Renal Transplantation
  • Organized by Novartis
  • Friday 23 September – 18:00 – 18:45
  • Title  Speaker
    Induction and Infection in Renal Transplantation Narayan Prasad
    Panel discussion

    Alan Almeida

    Pratik Das

    Sunil Prakash

  • Extracorporeal Hemoadsorption in Critically Ill Patients 
  • Organized by Biocon Biologics
  • Moderator: Vijay Kher
  • Saturday 24 September – 7:30 – 8:15
  • Time Title Speaker
    Extracorporeal hemoadsorption in critically ill patients Rajib Paul
    The importance of the right patient selection, timing and dosing Rajib Paul
    Panel discussion

    Sanjiv Jasuja

    Rajib Paul

    AVSSN Sridhar

    Vinant Bharghava

  • Finerenone: A New Hope for Improved Cardiorenal Outcomes in Patients with CKD in T2D
  • Organized by Bayer
  • Saturday 24 September – 12:45 – 13:45
  • Moderator: Vivekanand Jha
  • Title Speaker
    CKD in T2D: How urgently do we heed the call for treatment? Sanjeev Gulati
    Cardiorenal protection in patients with CKD and T2D: From FIDELIO-DKD to FIDELITY Dinesh Khullar
    Practical use of Finerenone: Whom to treat, when and how? Alan Almeida
    Panel discussion

    Vivekanand Jha

    Dinesh Khullar

    Sanjeev Gulati

    Alan Almeida

  • Protecting the Kidneys from COVID-19 Infection and Reducing Renal Risk Across the Spectrum – From Pre to Post Renal Replacement
  • Organized by AstraZeneca
  • Sunday 25 September – 12:45 – 13:45
  • Title Speaker
    Novel therapies for CKD – Targeting the different drivers of kidney disease Vijay Kher
    Panel discussion on How to use SGLT2 inhibitors in clinical practice for CKD

    Moderator: Prem Prakash Varma

    Vijay Kher

    Anil Kumar Bhalla

    Sanjeev Gulati

    Urmila Anandh

    Impact of COVID on CKD management and emerging Monoclonal Antibodies for prophylaxis of high risk patients

    Chair: Vijay Kher

    Dorry Segev

Industry exhibitors 

Abbott-logo Biocon Biokindle logofourrts logointas logola renon logoneuten healthcare logorencord logowockhardt nephrology logo